Inventor · disambiguated record
Steven Grant
Also filed as: GRANT SR STEVEN · GRANT STEVEN · GRANT STEVEN D · GRANT STEVEN DARYL
32 granted patents·21 pending applications·276 citations·filing 1982–2024
97Inventor score
Files withBRISTOL MYERS SQUIBB CO9DOMANTIS LTD9BIOSCEPTRE AUST PTY LTD4GLAXOSMITHKLINE IP DEV LTD4DENT PAUL2
Top patents by PatentIndex Score
53 records- 0196US7563443B2Monovalent anti-CD40L antibody polypeptides and compositions thereofDOMANTIS LTD·Filed 2005·Granted Jul 21, 2009·42 cites·40 claims
- 0294US9127059B2Anti P2X7 receptor antibodies and fragments thereofBARDEN JULIAN ALEXANDER·Filed 2010·Granted Sep 8, 2015·15 cites·6 claims
- 0394US8895010B2Antibody polypeptides that antagonize CD40LBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Nov 25, 2014·24 cites·36 claims
- 0492US9688771B2Anti P2X7 receptor antibodies and fragments thereofBIOSCEPTRE INT LTD·Filed 2015·Granted Jun 27, 2017·6 cites·15 claims
- 0591US9475879B2Antibody polypeptides that antagonize CD40SURI ANISH·Filed 2012·Granted Oct 25, 2016·31 cites·15 claims
- 0691US9228018B2Antibody polypeptides that antagonize CD40LBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 5, 2016·11 cites·35 claims
- 0789US2025084161A1Anti p2x7 receptor antibodies and fragments thereofBIOSCEPTRE AUST PTY LTD·Filed 2024·Application pending·0 cites
- 0888US10053508B2Anti P2X7 receptor antibodies and fragments thereofBIOSCEPTRE AUST PTY LTD·Filed 2017·Granted Aug 21, 2018·5 cites·15 claims
- 0988US9765150B2Antibody polypeptides that antagonize CD40LBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 19, 2017·5 cites·37 claims
- 1088US8981072B2Nucleic acids encoding antibody polypeptides that antagonize CD40LBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 17, 2015·8 cites·27 claims
- 1187US10988532B2Anti P2X7 receptor antibodies and fragments thereofBIOSCEPTRE AUST PTY LTD·Filed 2018·Granted Apr 27, 2021·2 cites·16 claims
- 1285US7927596B2Methods of antagonizing binding of CD40 to CD40L with CD40L-specific monovalent polypeptidesDOMANTIS LTD·Filed 2009·Granted Apr 19, 2011·5 cites·73 claims
- 1384US7829096B2CD40L-specific monovalent polypeptidesDOMANTIS LTD·Filed 2009·Granted Nov 9, 2010·4 cites·99 claims
- 1483US8926467B2Transmission with reverse drive assemblyHARLEY DAVIDSON MOTOR CO INC·Filed 2013·Granted Jan 6, 2015·6 cites·24 claims
- 1581US11142284B2Drive belt assembly for an electric vehicleHARLEY DAVIDSON MOTOR CO INC·Filed 2019·Granted Oct 12, 2021·5 cites·19 claims
- 1679US8324350B2Dual-specific IL-1α/IL-1β antibodiesHSIEH CHUNG-MING·Filed 2007·Granted Dec 4, 2012·3 cites·92 claims
- 1778US10196451B2Methods of treating immune diseases by administering antibody polypeptides that specifically bind CD40LBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Feb 5, 2019·1 cites·20 claims
- 1878US2022073636A1Antibody polypeptides that antagonize cd40lBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1977US8092800B2Antibodies against Candida antigensCASSONE ANTONIO·Filed 2006·Granted Jan 10, 2012·4 cites·56 claims
- 2076US12129295B2Anti P2X7 receptor antibodies and fragments thereofBIOSCEPTRE AUST PTY LTD·Filed 2021·Granted Oct 29, 2024·0 cites·16 claims
- 2176US10787509B2Biopharmaceutical compositions and related methodsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Sep 29, 2020·1 cites·11 claims
- 2276US2024417456A1Biopharmaceutical compositions and related methodsGLAXOSMITHKLINE IP DEV LTD·Filed 2024·Application pending·0 cites
- 2374US6422786B1Air-cooled gearbox assemblyWACKER CORP·Filed 2000·Granted Jul 23, 2002·15 cites·19 claims
- 2473US10544228B2Nucleic acids encoding antibody polypeptides that antagonize CD40BRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 28, 2020·1 cites·17 claims
- 2573US6147107ASpecific inhibition of the P42/44 mitogen activated protein (map) kinase cascade sensitizes tumor cellsUNIV VIRGINIA COMMONWEALTH·Filed 1998·Granted Nov 14, 2000·38 cites·20 claims
- 2672US7358096B1Immobilisation of proteinsCONOPCO INC·Filed 2000·Granted Apr 15, 2008·2 cites·13 claims
- 2771US11180567B2Antibody polypeptides that antagonize CD40LBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 23, 2021·0 cites·20 claims
- 2871US10619913B2Body cooling assemblyGRANT MICHAEL·Filed 2017·Granted Apr 14, 2020·1 cites·8 claims
- 2969US8524236B2Methods of antagonizing the binding of CD40 to CD40L with CD40L-specific monovalent polypeptides in autoimmune individualsGRANT STEVEN·Filed 2005·Granted Sep 3, 2013·1 cites·43 claims
- 3065US11976113B2Biopharmaceutical compositions comprising nucleic acids encoding IL-5 binding proteinsGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted May 7, 2024·0 cites·16 claims
- 3164US11136406B2Methods of treating immune diseases by administering antibody polypeptides that antagonize CD40BRISTOL MYERS SQUIBB CO·Filed 2019·Granted Oct 5, 2021·0 cites·20 claims
- 3261US2009264439A1Combination of a) N--4-(3-pyridyl)-2-pyrimidine-amine and b) a histone deacetylase inhibitor for the treatment of leukemiaDENT PAUL·Filed 2009·Application pending·0 cites
- 3360US7888341B2Combination of glivec (STI571) with a cyclin-dependent kinase inhibitor, especially flavopiridol, in the treatment of cancerUS DEPT VETERANS AFFAIRS·Filed 2003·Granted Feb 15, 2011·2 cites·6 claims
- 3458US2005271663A1Compositions and methods for treating inflammatory disordersDOMANTIS LTD·Filed 2004·Application pending·0 cites
- 3556US2009258012A1Compositions and methods for treating inflammatory disordersDOMANTIS LTD·Filed 2009·Application pending·0 cites
- 3656US2010081792A1LigandSMITHKLINE BEECHAM CORP·Filed 2007·Application pending·0 cites
- 3755US2013171146A1Dual-specific il-1a/ il-1b antibodiesHSIEH CHUNG-MING·Filed 2012·Application pending·0 cites
- 3854US2011097339A1Compositions monovalent for CD28 binding and methods of useDOMANTIS LTD·Filed 2009·Application pending·0 cites
- 3954US2011172400A1Compositions monovalent for cd40l binding and methods of useDOMANTIS LTD·Filed 2010·Application pending·0 cites
- 4053US6250844B1Concrete finishing trowel with improved rotor assembly drive systemWACKER CORP·Filed 1999·Granted Jun 26, 2001·23 cites·31 claims
- 4150US11613571B2Biopharmaceutical compositions comprising antibody variantsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Mar 28, 2023·0 cites·19 claims
- 4250US4440771A2-Acetyl quinoline thiosemicarbazones useful in treatment of gonorrhea, malaria or bacterial infectionsUS ARMY·Filed 1982·Granted Apr 3, 1984·15 cites·54 claims
- 4350US2005211180A1Aquarium tankGRANT STEVEN J·Filed 2005·Application pending·0 cites
- 4448US2006081671A1Hip support for a golf bagGRANT STEVEN W·Filed 2004·Application pending·0 cites
- 4548US2005004007A1Promotion of adoptosis in cancer cells by co-administration of cyclin dependent kinase inhibitiors and cellular differentiation agentsFiled 2001·Application pending·0 cites
- 4643US2009105200A1Combination therapyKEEGAN MITCHELL·Filed 2008·Application pending·0 cites
- 4742US2004191168A1Tumor cell killing by cell cycle checkpoint abrogation combined with Inhibition of the classical mitogen activated protein (map) kinase pathwayFiled 2001·Application pending·0 cites
- 4840US2013216538A1Compositions and Methods for Treating Inflammatory DisordersDOMANTIS LTD·Filed 2013·Application pending·0 cites
- 4940US2006100140A1Combination of a) n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]2-methylphenyl}-4- (3-pyridyl)-2-pyrimidine-amine and b) a histone deacetylase inhibitor for the treatment of leukemiaDENT PAUL·Filed 2003·Application pending·0 cites
- 5038US2006073141A1Compositions and methods for treating inflammatory disordersDOMANTIS LTD·Filed 2005·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →